Digklia Antonia, Tzika Evangelia, Voutsadakis Ioannis A
Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
J Oncol Pharm Pract. 2014 Apr;20(2):146-8. doi: 10.1177/1078155213480535. Epub 2013 May 14.
Aromatase inhibitors are increasingly used in the treatment of early and metastatic breast cancer. They can produce various skin adverse effects but are only rarely associated with cutaneous vasculitis. We report the first case of cutaneous vasculitis clearly associated with the use of aromatase inhibitor letrozole.
芳香化酶抑制剂越来越多地用于治疗早期和转移性乳腺癌。它们可产生各种皮肤不良反应,但仅很少与皮肤血管炎相关。我们报告首例明确与使用芳香化酶抑制剂来曲唑相关的皮肤血管炎病例。